Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to 0.26.

  • Utah Medical Products' FCF Payout Ratio fell 813.22% to 0.26 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29, marking a year-over-year increase of 1478.93%. This contributed to the annual value of 0.29 for FY2024, which is 4746.12% up from last year.
  • Per Utah Medical Products' latest filing, its FCF Payout Ratio stood at 0.26 for Q3 2025, which was down 813.22% from 0.35 recorded in Q2 2025.
  • Utah Medical Products' FCF Payout Ratio's 5-year high stood at 1.76 during Q4 2021, with a 5-year trough of 0.16 in Q1 2023.
  • Over the past 5 years, Utah Medical Products' median FCF Payout Ratio value was 0.23 (recorded in 2021), while the average stood at 0.33.
  • Per our database at Business Quant, Utah Medical Products' FCF Payout Ratio surged by 89067.6% in 2021 and then crashed by 8943.76% in 2022.
  • Utah Medical Products' FCF Payout Ratio (Quarter) stood at 1.76 in 2021, then plummeted by 89.44% to 0.19 in 2022, then rose by 9.68% to 0.2 in 2023, then skyrocketed by 73.51% to 0.35 in 2024, then fell by 27.63% to 0.26 in 2025.
  • Its FCF Payout Ratio was 0.26 in Q3 2025, compared to 0.35 in Q2 2025 and 0.24 in Q1 2025.